Cargando…

Advances in medicine and biology. Volume 18 /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Berhardt, Leon V.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Nova Science Publishers, ©2011.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • ADVANCES IN MEDICINE AND BIOLOGY. VOLUME 18; ADVANCES IN MEDICINE AND BIOLOGY. VOLUME 18; CONTENTS; PREFACE; STUDY OF MYELOPROTECTIVE ACTIVITYOF PHARMACOLOGICAL AGENT NOVOGEN, UNDER CONDITIONS OF DURABLE INFLUENCEOF CHLORAMPHENICOL ON ORGANISM; INVESTIGATION MATERIALS AND METHODS; REFERENCES; ASSESSMENT OF SERUM ASCORBIC ACID LEVELSIN SOME SELECTED SURGICAL DISEASESAND IMPLICATIONS FOR WOUND HEALINGAND SURGERY- INDUCED OXIDATIVE STRESS; ABSTRACT; INTRODUCTION; PATIENTS AND METHODS; Patients and Study Design; Serum Sample Collection and Preparation; Assay for Serum Ascorbic Acid.
  • Statistical AnalysisEthics; RESULTS; DISCUSSION; REFERENCES; INDICATIONS AND MANAGEMENT OF M-TORINHIBITORS AFTER LIVER TRANSPLANTATION; ABSTRACT; INTRODUCTION; Objectives; MATERIAL AND METHODS; DEMOGRAPHIC CHARACTERISTICS; Data Analysis; RESULTS; Efficacy; Liver Graft Function after Conversion; Side Effects and Discontinuation; Pharmacokinetics; Patient Survival and Follow-Up; DISCUSSION; REFERENCES; LIVER TRANSPLANTATION: THERAPY; INTRODUCTION; ACUTE CELLULAR REJECTION; Allograft Recognition; T-Cell Activation; Clonal Expansion; Inflammation; IMMUNOSUPPRESSIVE AGENTS.
  • USE OF IMMUNOSUPPRESSIVE AGENTS IN LIVER TRANSPLANTATIONIN THE UNITED STATES. CALCINEURIN INHIBITORS-CYCLOSPORINE AND TACROLIMUS; Background; Mechanism of Action; Pharmacokinetics and Pharmacodynamics; Side Effects; Drug Interactions; Clinical use in Liver Transplantation; CORTICOSTEROIDS; Background; Mechanism of Action; Side Effects; Drug Interactions; Clinical use in Liver Transplantation; RAPAMYCIN; Background; Mechanism of Action; Pharmacokinetics and Pharmacodynamics; Side Effects; Drug Interactions; Clinical use in Liver Transplantation; PURINE SYNTHESIS INHIBITORS.
  • MYCOPHENOLATE MOFETILBackground; Mechanism of Action; Pharmacokinetics and Pharmacodynamics; Side Effects; Drug Interactions; Clinical use in Liver Transplantation; ANTILYMPHOCYTIC ANTIBODY THERAPY; MONOCLONAL ANTI-T- CELL RECEPTOR ANTIBODIES; Background/Discover; Mechanism of Action; Pharmcokinetics and Pharmocodynamics; Side Effects; Clinical use; POLYCLONAL ANTIBODIES; Background; Mechanism of Action; Pharmacokinetics and Pharmacodynamics; Side Effects; Clinical use; ALEMTUZUMAB/CAMPATH-1-H; INTERLEUKIN-2 RECEPTOR ANTIBODIES; Mechanism of Action; Pharmacokinetics and Pharmacodynamics.
  • Clinical useIMMUNOSUPPRESSANTS IN DEVELOPMENT; FK 778; JAK3 Inhibitors; FTY 720; BELATACEPT-COSTIMULATORY SIGNAL BLOCKADE; SUMMARY; REFERENCES; HISTOPATHOLOGICAL ANDIMMUNOHISTOCHEMICAL BACKGROUNDOF ORTHODONTIC TREATMENT; ABSTRACT; INTRODUCTION; DEVELOPING MANDIBULAR BODY BONE; DEVELOPING MANDIBULAR CARTILAGES; REGULATION FACTORS IN MORPHOGENESIS OF MANDIBULARCONDYLAR CARTILAGE; PERIODONTAL TISSUE REACTIONS IN ORTHODONTIC TREATMENT; PERIODONTAL TISSUE REACTION TO CELL INJURY STIMULATION; REFERENCES; REPERCUSSION OF MYTHS, BELIEFS AND PRACTICESON CHILDREN'S ORAL HEALTH; SUMMARY; INTRODUCTION.